Personalized medicine depends on tools, such as immunohistochemistry (IHC), that identify precise targets in a patient’s disease. Immunohistochemistry (IHC) staining is integral in developing ...
Immunohistochemistry uses antibodies to test tissue samples for specific types of antigens. It can often provide very specific results regarding cancer types or other diseases, helping doctors decide ...
In clinical routine pathology today, detection of protein in intact formalin-fixed, paraffin-embedded tissue is limited to immunohistochemistry, which is semi-quantitative. This study presents a new ...
The first study using IHC was published in the 1940s when antigens of bacterial species Streptococcus pneumonia were discovered in the tissues. Since then, a wealth of developments and several ...
A retrospective, cross-sectional study analyzed national trends of immunohistochemistry (IHC) use in the diagnosis of melanoma. Immunohistochemistry (IHC) has emerged as a clinical tool in skin ...
There is a low probability of success for immuno-oncology (IO) research. There is a below average likelihood-of-approval rate for oncology, usually 5.3% vs. 7.9% for all indications. The clinical ...
Cancer incidence is increasing in sub-Saharan Africa, yet there is little information on the capacity of pathology laboratories in this region. We aimed to assess the current state of pathology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback